Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded by StockNews.com to "Sell" : vimarsana.com

StockNews.com upgraded shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) to a sell rating in a research note released on Friday morning. A number of other research analysts have also weighed in on the company. William Blair reaffirmed an outperform rating on shares of Rocket Pharmaceuticals in a report on Wednesday, March 22nd. Chardan Capital […]

Related Keywords

John Militello , William Blair , News Ratings For Rocket Pharmaceuticals Daily , Rocket Pharmaceuticals , Securities Exchange Commission , Rocket Pharmaceuticals Inc , Needham Company , Analyst Recommendations For Rocket Pharmaceuticals , Rocket Pharmaceuticals Company Profile , Synovus Financial Corp , Jpmorgan Chase Co , Institutional Trading Of Rocket Pharmaceuticals , Rocket Pharmaceuticals Price Performance , Metlife Investment Management , Hightower Advisors , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Tower Advisors , Life Investment Management , Financial Corp , Rocket Pharmaceuticals Daily , Nasdaq Rckt , Rckt , Medical , Upgrade , Stocknews Com ,